Bridgewater Associates’s Chemours CC Stock Holding History
Bought
Maintained
Sold
Other funds holding CC
CCPM
Bridgewater Associates's CC Position: Q2 2026 in Review
Bridgewater Associates reduced its Chemours (CC) stake by 73% in Q2 2026, selling an estimated $2.51M and leaving 39,556 shares worth $812K. The position accounts for ﹤0.01% of the portfolio, ranked #862.
Bridgewater Associates first reported a position in CC in Q3 2020 and has held it in 14 quarters since. The position peaked at $7.26M in Q3 2023. 474 funds tracked by Wall St. Rank hold CC as of Q2 2026.
- Bridgewater Associates held 39,556 shares of Chemours worth $812K as of Q2 2026.
- Bridgewater Associates sold 109,701 Chemours shares in Q2 2026, an estimated $2.51M.
- Chemours made up ﹤0.01% of Bridgewater Associates's portfolio in Q2 2026, its #862 holding.
- Bridgewater Associates first reported a position in Chemours in Q3 2020 and has held it in 14 quarters since.
- Bridgewater Associates's Chemours position peaked at $7.26M in Q3 2023.
- 474 funds tracked by Wall St. Rank held Chemours as of Q2 2026.
Based on Bridgewater Associates's 13F filing for Q2 2026, filed 14 Aug 2026.